Life Sciences Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 17
Professionals
  • Investments
  • 180
  • Portfolio
  • 45
  • Exits
  • 83
Exits

Life Sciences Partners General Information

Description

Founded in 1988, Life Sciences Partners is a venture capital firm based in Amsterdam, The Netherlands. The firm seeks to make minority seed, early-stage, and later-stage investments. The firm prefers to invest in the pharmaceuticals, biotechnology, and life sciences sectors in the United States and Western Europe.

Contact Information

Website
Year Founded
1988
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Impact Investing
Primary Office
  • Johannes Vermeerplein 9
  • 1071 DV Amsterdam
  • Netherlands
+31 020 000 0000

Life Sciences Partners Investments (180)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cardiac Dimensions 28-Sep-2020 Later Stage VC 000.00 Therapeutic Devices Generating Revenue 00000 00000 00.0
0000000 0000000000 15-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000000 00000000 00.0
00000000000 07-Sep-2020 00000 00000 0000 Surgical Devices Product Development 0000 000000 00.0
000 000000 29-Jul-2020 00000 00000 0000 Biotechnology Generating Revenue 0000000 00000 00.0
0000 000000000000 15-Jul-2020 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 000000000
000000 08-Jul-2020 00000 00000 000.00 Enterprise Systems (Healthcare) Generating Revenue 0000 00000000 00.0
0000000 (000000000 07-Jul-2020 00000 00000 000.00 Therapeutic Devices Generating Revenue 0000 00000000 00.0
00000 03-Jul-2020 00000 00000 0000 Drug Discovery Startup 0000 00 000000 00.0
eTheRNA Immunotherapies 16-Jun-2020 Later Stage VC 000.00 Biotechnology Clinical Trials - General 0000 00 000000 00.0
Arvelle Therapeutics 26-May-2020 Early Stage VC 00000 Biotechnology Generating Revenue 0000000 000000000
You’re viewing 10 of 180 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Life Sciences Partners Exits (82)

Company Name Exit Date Exit Type Exit Size
Nkarta Therapeutics 13-Jul-2020 IPO 00000
0000000000 01-May-2020 0000000000
0000000 0000000000 12-Apr-2019 0000000 000000
00000000000000 11-Feb-2019 000 000.00
0000000 31-Jul-2018 000000000000000000 00000
000000000 23-May-2018 000000000000000000
0000000 0000000 26-Apr-2018 000000000000000000
0000000 0000000 25-Apr-2018 0000000000: 000000
Eloxx Pharmaceuticals 19-Dec-2017 Reverse Merger
Argenx 14-Dec-2017 Public Investment 2nd Offering 00000
You’re viewing 10 of 82 exits. Get the full list »

Life Sciences Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Life Sciences Partners Team (32)

Name Title Deals Funds Boards Office
Merijn Klaassen Chief Financial Officer & Partner Amsterdam, Netherlands
Martijn Kleijwegt Co-Owner & Managing Partner 00 0 0 Amsterdam, Netherlands
Mark Wegter Managing Partner 0 0 Amsterdam, Netherlands
René Kuijten Ph.D Managing Partner 00 0 0 Amsterdam, Netherlands
Rudy Dekeyser Ph.D Managing Partner 0 0 0 Amsterdam, Netherlands
You’re viewing 5 of 32 team members. Get the full list »

Life Sciences Partners Co-Investors (156)

Name With Exits Lead Partner Series Industry
Kurma Partners 9 00 Series chart Industry bar
Idinvest Partners 0 0 Series chart Industry bar
Ysios Capital 0 0 Series chart Industry bar
Andera Partners 0 0 Series chart Industry bar
Novartis Venture Fund 0 0 Series chart Industry bar
You’re viewing 5 of 156 co-investors. Get the full list »